Navigation Links
The Future of R&D Outsourcing

NEW YORK, Aug. 9, 2012 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

The Future of R&D Outsourcing

Current industry trends are examined as the context of This report summarizes the current landscape for outsourcing in the pharmaceutical industry, identifying emerging trends and predicting important models for the future. A review of traditional and emerging working relationships between pharma and CRO are also presented.Understand different sponsor/CRO working models currently practiced.Identify emerging and future trends in the outsourcing market.Understand the benefits of innovative partnership arrangements between pharma and CRO.Identify the services of greatest importance in the outsourcing market.Forecast the CRO market to 2016.

The use of outsourcing has developed over the last 10 years from a tactical commodity exchange to a full strategic partnership involving sharing of goals and objectives, milestones, knowledge, processes, and in some cases, risks. This trend is predicted to continue over the coming 5–10 years.

Offering drug discovery and preclinical research facilities supports full-service CROs in their position as sole providers for large pharmaceutical companies. The global market in drug discovery and preclinical outsourcing is expected to continue to show strong growth over the short to medium term.

CROs are leading the field in the development of innovative solutions to improve clinical trial efficiency, including the use of adaptive design trials. Adaptive design improves efficiency by reducing waste and shortening timelines.

What models of outsourcing will dominate over the next 5 to 10 years?How can manufacturers and CROs work together more effectively to accelerate drug development?How can manufacturers and CROs work together more effectively to accelerate drug development?Which parts of the R&D process are best suited to outsourcing?Which group of outsourcing providers will face the toughest conditions to 2017?

To order this report:Research and Development Industry: The Future of R&D Outsourcing


Market Research Report

Check our  

Industry Analysis and Insights

Nicolas Bombourg



US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardinal Health Supports Future Pharmacists With Nearly $1 Million In Scholarships
2. Lippincott Williams & Wilkins Launches Electronic Health Record (EHR) Learning Tool to Help Future Nurses Prepare for New Practice Requirements
3. TeNS Medical Services: Blogging for a Pain Free Future
4. The New Generation of Antibody Therapeutics: Current Status and Future Prospects - Overview
5. Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With in Quarterly Series
6. Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Targets
7. Berg Pharma and the Parkinsons Institute ink R&D collaboration to drive disease understanding and accelerate therapeutic and diagnostic development in Parkinsons Disease
8. Denton Vacuum Ships Breakthrough Wafer-level Optics Development System to Leading German R&D Organization
9. Abbott Announces Collaboration with Syngene to Open First Nutrition R&D Center in India
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. New White Paper, "Five Biggest Myths about Medical Products Outsourcing," Finds OEMs Concerns are Often Unfounded
Post Your Comments:
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... 2016 , , , WHEN: ... 2016 , , , , LOCATION: , , , Online, ... , , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global ... Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager ... pharmaceutical industry is witnessing an exceptional era. Several new demand spaces, ...
(Date:6/23/2016)... the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... Sandra ... ... Astellas is a pharmaceutical company ...
Breaking Medicine Technology:
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
Breaking Medicine News(10 mins):